Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Change in Account Payables: 2020-2022

Historic Change in Account Payables for Atea Pharmaceuticals (AVIR) over the last 3 years, with Dec 2022 value amounting to $1.4 million.

  • Atea Pharmaceuticals' Change in Account Payables rose 108.12% to $1.4 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$2.0 million, marking a year-over-year decrease of 119.27%. This contributed to the annual value of $206,000 for FY2024, which is 87.89% down from last year.
  • According to the latest figures from Q4 2022, Atea Pharmaceuticals' Change in Account Payables is $1.4 million, which was up 111.22% from -$12.8 million recorded in Q3 2022.
  • Over the past 5 years, Atea Pharmaceuticals' Change in Account Payables peaked at $12.7 million during Q2 2021, and registered a low of -$17.7 million during Q4 2021.
  • Moreover, its 3-year median value for Change in Account Payables was $1.2 million (2020), whereas its average is $651,500.
  • Examining YoY changes over the last 5 years, Atea Pharmaceuticals' Change in Account Payables showed a top increase of 2,588.00% in 2021 and a maximum decrease of 322.70% in 2021.
  • Atea Pharmaceuticals' Change in Account Payables (Quarterly) stood at -$4.2 million in 2020, then slumped by 322.70% to -$17.7 million in 2021, then spiked by 108.12% to $1.4 million in 2022.
  • Its Change in Account Payables stands at $1.4 million for Q4 2022, versus -$12.8 million for Q3 2022 and $10.2 million for Q2 2022.